Cargando…

A short review of drug–food interactions of medicines treating overactive bladder syndrome

Background Overactive bladder syndrome is a condition where one or more of the symptoms such as pollakiuria, urgent need to urinate, nocturia and urinary incontinence is observed. Its prevalence ranges between 7 and 27 % in men and 9–43 % in women. The role of a pharmacist is to educate the patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Paśko, Paweł, Rodacki, Tomasz, Domagała-Rodacka, Renata, Owczarek, Danuta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124029/
https://www.ncbi.nlm.nih.gov/pubmed/27738922
http://dx.doi.org/10.1007/s11096-016-0383-5
_version_ 1782469792274317312
author Paśko, Paweł
Rodacki, Tomasz
Domagała-Rodacka, Renata
Owczarek, Danuta
author_facet Paśko, Paweł
Rodacki, Tomasz
Domagała-Rodacka, Renata
Owczarek, Danuta
author_sort Paśko, Paweł
collection PubMed
description Background Overactive bladder syndrome is a condition where one or more of the symptoms such as pollakiuria, urgent need to urinate, nocturia and urinary incontinence is observed. Its prevalence ranges between 7 and 27 % in men and 9–43 % in women. The role of a pharmacist is to educate the patient on medications administration scheme, and drug interactions with particular food or food components. Aim of the review To assess a potential impact of food and fruit juice on the pharmacokinetic and therapeutic effects of medications used in treating overactive bladder syndrome. This information will enhance pharmaceutical care and is vital and helpful for pharmacists counseling their patients. Method In order to gather information on interactions of medications employed in bladder dysfunctions, the English language reports published in the PubMed, Embase, Cochrane and CINAHL database over the years 1996–2015 were studied. Additionally, other resources, namely drugs.com, Medscape, UpToDate, Micromedex, Medical Letter, as well as Stockley Drugs Interaction electronic publication were included in the study. The analysis also covered product data sheets for particular medicinal products. Results Meals and the consumption of grapefruit juice were found to exert a diversified effect on the pharmacokinetics of drugs employed in overactive bladder syndrome therapy. Neither tolterodine, nor mirabegron interact with food and citrus fruit juice, whereas darifenacin, fesoterodine, oxybutynin and solifenacin do interact with grapefruit and others citrus fruit juice. The effects of such interactions may potentially be negative to patients. Trospium absorption is significantly decreased by food. Conclusion For selected medicines used in treating bladder dysfunctions food and grapefruit juice consumption may significantly affect efficacy and safety of the therapy. All information on the topic is likely to enhance the quality of pharmaceutical care.
format Online
Article
Text
id pubmed-5124029
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-51240292016-12-09 A short review of drug–food interactions of medicines treating overactive bladder syndrome Paśko, Paweł Rodacki, Tomasz Domagała-Rodacka, Renata Owczarek, Danuta Int J Clin Pharm Review Article Background Overactive bladder syndrome is a condition where one or more of the symptoms such as pollakiuria, urgent need to urinate, nocturia and urinary incontinence is observed. Its prevalence ranges between 7 and 27 % in men and 9–43 % in women. The role of a pharmacist is to educate the patient on medications administration scheme, and drug interactions with particular food or food components. Aim of the review To assess a potential impact of food and fruit juice on the pharmacokinetic and therapeutic effects of medications used in treating overactive bladder syndrome. This information will enhance pharmaceutical care and is vital and helpful for pharmacists counseling their patients. Method In order to gather information on interactions of medications employed in bladder dysfunctions, the English language reports published in the PubMed, Embase, Cochrane and CINAHL database over the years 1996–2015 were studied. Additionally, other resources, namely drugs.com, Medscape, UpToDate, Micromedex, Medical Letter, as well as Stockley Drugs Interaction electronic publication were included in the study. The analysis also covered product data sheets for particular medicinal products. Results Meals and the consumption of grapefruit juice were found to exert a diversified effect on the pharmacokinetics of drugs employed in overactive bladder syndrome therapy. Neither tolterodine, nor mirabegron interact with food and citrus fruit juice, whereas darifenacin, fesoterodine, oxybutynin and solifenacin do interact with grapefruit and others citrus fruit juice. The effects of such interactions may potentially be negative to patients. Trospium absorption is significantly decreased by food. Conclusion For selected medicines used in treating bladder dysfunctions food and grapefruit juice consumption may significantly affect efficacy and safety of the therapy. All information on the topic is likely to enhance the quality of pharmaceutical care. Springer International Publishing 2016-10-13 2016 /pmc/articles/PMC5124029/ /pubmed/27738922 http://dx.doi.org/10.1007/s11096-016-0383-5 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review Article
Paśko, Paweł
Rodacki, Tomasz
Domagała-Rodacka, Renata
Owczarek, Danuta
A short review of drug–food interactions of medicines treating overactive bladder syndrome
title A short review of drug–food interactions of medicines treating overactive bladder syndrome
title_full A short review of drug–food interactions of medicines treating overactive bladder syndrome
title_fullStr A short review of drug–food interactions of medicines treating overactive bladder syndrome
title_full_unstemmed A short review of drug–food interactions of medicines treating overactive bladder syndrome
title_short A short review of drug–food interactions of medicines treating overactive bladder syndrome
title_sort short review of drug–food interactions of medicines treating overactive bladder syndrome
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124029/
https://www.ncbi.nlm.nih.gov/pubmed/27738922
http://dx.doi.org/10.1007/s11096-016-0383-5
work_keys_str_mv AT paskopaweł ashortreviewofdrugfoodinteractionsofmedicinestreatingoveractivebladdersyndrome
AT rodackitomasz ashortreviewofdrugfoodinteractionsofmedicinestreatingoveractivebladdersyndrome
AT domagałarodackarenata ashortreviewofdrugfoodinteractionsofmedicinestreatingoveractivebladdersyndrome
AT owczarekdanuta ashortreviewofdrugfoodinteractionsofmedicinestreatingoveractivebladdersyndrome
AT paskopaweł shortreviewofdrugfoodinteractionsofmedicinestreatingoveractivebladdersyndrome
AT rodackitomasz shortreviewofdrugfoodinteractionsofmedicinestreatingoveractivebladdersyndrome
AT domagałarodackarenata shortreviewofdrugfoodinteractionsofmedicinestreatingoveractivebladdersyndrome
AT owczarekdanuta shortreviewofdrugfoodinteractionsofmedicinestreatingoveractivebladdersyndrome